Pain control in breast surgery: analgesia, opioide consumption and inflamatory response evaluatio

Not Applicable

• Conditions: Patients with breast neoplasia CID10 D-48 and deCS C04.588.180; C00-D48; C04.588.180

• Registration Number: RBR-2fjmhz
• Lead Sponsor: Hospital Sírio-Libanês

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-10-31
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

Patients ASA I and II submitted to radical mastectomy with breast reconstruction

Exclusion Criteria

Patients with allergy to local anesthesic, patients with chronic pain previous to surgery

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The postoperative pain will be assessed using the Visual Analogue Scale pain in the recovery room and 24 hours after surgery. It is expected a reduction in 1.5 points in this scale considering patients that belong to the block group.

Secondary Outcome Measures

Name	Time	Method
Reduction in the inflamatory profile (seric cytokines), measured using Elisa method, from blood samples collected before and 24h after the surgery, considering variation of at least 5%.